Hoshi N, Ueno K, Igarashi T, Kitagawa H, Fujita T, Ichikawa N, Kondo Y, Isoda M
J Toxicol Sci. 1985 Oct;10 Suppl 2:227-34. doi: 10.2131/jts.10.supplementii_227.
A teratological study was carried out in New Zealand White rabbits in order to examine the teratogenic potentiality of HPMCAS, a useful pharmaceutical excipient. HPMCAS was orally administered at dose levels of 625, 1,250 and 2,500 mg/kg/day for a period of 13 days from day 6 to day 18 of gestation. All pregnant females were sacrificed on day 29 of gestation and their fetuses were examined. The administration of HPMCAS during a period of organogenesis produced no embryotoxic and teratogenic effects as well as no influence on behavior, appearance and growth of animals.
为了检测一种有用的药用辅料羟丙基甲基纤维素醋酸琥珀酸酯(HPMCAS)的致畸潜力,在新西兰白兔身上进行了一项致畸学研究。从妊娠第6天至第18天,以625、1250和2500mg/kg/天的剂量水平对HPMCAS进行口服给药,持续13天。所有怀孕母兔在妊娠第29天处死,并对其胎儿进行检查。在器官形成期给予HPMCAS未产生胚胎毒性和致畸作用,对动物的行为、外观和生长也没有影响。